Back
Endava plc - ADR Vs. Nektar Therapeutics Industry Stock Comparison
Sell
42
DAVA
Endava plc - ADR
Last Price:
$13.68
Seasonality Move:
2.32%
Buy
51
NKTR
Nektar Therapeutics
Last Price:
$25.74
Seasonality Move:
4.65%
Sell
42
Endava plc - ADR (DAVA)
is a Sell
Is Endava plc - ADR a Buy, Sell or Hold?
-
The current Endava plc - ADR [DAVA] share price is $13.70. The Score for DAVA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $23.60. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava plc - ADR's stock price today?
-
The Endava plc - ADR share price today is $13.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAVA is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $23.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.34 | Buy |
Relative Strength Index (14 RSI): | 52.11 | Buy |
Chaikin Money Flow: | 560906 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.43 | Buy |
Relative Strength Index (14 RSI): | 54.83 | Buy |
Chaikin Money Flow: | 500230 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.41 | Buy |
20-day SMA: | 13.29 | Buy |
50-day SMA: | 14.38 | Sell |
200-day SMA: | 22.3 | Sell |
8-day EMA: | 12.1 | Buy |
20-day EMA: | 8.83 | Buy |
50-day EMA: | 4.81 | Buy |
200-day EMA: | 1.43 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.77 | Buy |
20-day SMA: | 23.6 | Sell |
50-day SMA: | 19.92 | Buy |
200-day SMA: | 15.01 | Buy |
8-day EMA: | 22.89 | Buy |
20-day EMA: | 22.9 | Buy |
50-day EMA: | 20.46 | Buy |
200-day EMA: | 16.32 | Buy |
Endava plc - ADR Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Endava plc - ADR Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |